Abbott Rewards Shareholders; Shares Record New All-Time High

Multinational medical devices and healthcare company, Abbott Laboratories (ABT) announced an increase in its quarterly cash common dividend for the 50^th consecutive year. Moreover, the Board also declared a new share buyback program.

Don't Miss our Black Friday Offers:

Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter

Following the news, shares reached a new all-time high of $134.50 and closed the day up 1.4% at $134.37 on December 10.

Rewarding Shareholders

Abbott, which is a part of The Dividend Aristocrat Index, increased its quarterly common dividend by 4.4% to $0.47 per share, following a 25% increase in its common dividend in 2021. This marks the 392^nd consecutive quarterly dividend paid by Abbott since 1924. The dividend is payable on February 15, 2022, to shareholders on record as of January 14, 2022.

Additionally, the company’s Board also approved a new share buyback program of up to $5 billion, in addition to the unused portion of the earlier program approved by the Board in 2019.

Management Comments

President, and CEO of Abbott, Robert B. Ford, said, “Fifty years of dividend growth reflects the consistently strong performance of our diversified business model… It exemplifies our longstanding commitment to delivering sustainable growth that fuels innovation as well as shareholder returns.”

See Analysts’ Top Stocks on TipRanks >>

Wall Street View

With 11 Buys and 2 Holds, the ABT stock commands a Strong Buy consensus rating. The average Abbott price target of $141.58 implies 5.37% upside potential to current levels. Shares have gained 25.8% over the past year.

Smart Score

According to TipRanks’ Smart Score rating system, Abbott scores a “Perfect 10”, which indicates that the stock has strong potential to outperform market expectations.